{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:30:04Z","timestamp":1761895804830,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["canadianjournalofdiabetes.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Diabetes"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.jcjd.2013.04.008","type":"journal-article","created":{"date-parts":[[2013,12,7]],"date-time":"2013-12-07T08:15:43Z","timestamp":1386404143000},"page":"394-400","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Use Patterns of Antidiabetic Regimens by Patients with Type\u00a02 Diabetes"],"prefix":"10.1016","volume":"37","author":[{"given":"Ahmed S.","family":"Abdelmoneim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean T.","family":"Eurich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John-Michael","family":"Gamble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scot H.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjd.2013.04.008_bib1","unstructured":"International Diabetes Federation. One adult in ten will have diabetes by 2030. http:\/\/www.idf.org\/media-events\/press-releases\/2011\/diabetes-atlas-5th-edition. Accessed: Febrary 13, 2013."},{"issue":"suppl 1","key":"10.1016\/j.jcjd.2013.04.008_bib2","first-page":"S1","article-title":"Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada","volume":"32","year":"2008","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcjd.2013.04.008_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(06)68967-8","article-title":"Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study","volume":"368","author":"Booth","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jcjd.2013.04.008_bib4","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2337\/dc09-0680","article-title":"Mortality trends in subjects with and without diabetes during 33 years of follow-up","volume":"33","author":"Jansson","year":"2010","journal-title":"Diabetes Care"},{"issue":"suppl 2","key":"10.1016\/j.jcjd.2013.04.008_bib5","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1007\/PL00002934","article-title":"Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes","volume":"44","author":"Morrish","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcjd.2013.04.008_bib6","first-page":"S1","article-title":"Canadian Diabetes Association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada","volume":"27","year":"2003","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcjd.2013.04.008_bib7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.diabres.2005.03.024","article-title":"Glycemic control and morbidity in the Canadian primary care setting (results of the diabetes in Canada evaluation study)","volume":"70","author":"Harris","year":"2005","journal-title":"Diabetes Res Clin Pract"},{"year":"2011","series-title":"National Cancer Institute. Joinpoint Regression Program, version 3.5.0 2011","key":"10.1016\/j.jcjd.2013.04.008_bib8"},{"key":"10.1016\/j.jcjd.2013.04.008_bib9","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"key":"10.1016\/j.jcjd.2013.04.008_bib10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/CIRCHEARTFAILURE.110.959262","article-title":"Patterns of care and outcomes differ for urban versus rural patients with newly diagnosed heart failure, even in a universal healthcare system","volume":"4","author":"Gamble","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jcjd.2013.04.008_bib11","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"issue":"suppl\u00a01","key":"10.1016\/j.jcjd.2013.04.008_bib12","first-page":"S1","article-title":"Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada","volume":"37","year":"2013","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcjd.2013.04.008_bib13","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jcjd.2013.04.008_bib14","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.2337\/diacare.26.6.1847","article-title":"Recent antihyperglycemic prescribing trends for US privately insured patients with type 2 diabetes","volume":"26","author":"Cohen","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2013.04.008_bib15","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/BF02849973","article-title":"Trends in the prescription of antidiabetic medications in France: evidence from primary care physicians","volume":"24","author":"Boyc","year":"2007","journal-title":"Adv Ther"},{"key":"10.1016\/j.jcjd.2013.04.008_bib16","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/pds.1802","article-title":"Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysis","volume":"18","author":"Filion","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jcjd.2013.04.008_bib17","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa072761","article-title":"Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes","volume":"356","author":"Nissen","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcjd.2013.04.008_bib18","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1111\/dme.12049","article-title":"Progression through diabetes therapies among new elderly users of metformin: a population-based study","volume":"30","author":"Gomes","year":"2013","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcjd.2013.04.008_bib19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1046\/j.1463-1326.2002.00211.x","article-title":"Simultaneous glyburide\/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes","volume":"4","author":"Garber","year":"2002","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jcjd.2013.04.008_bib20","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1463-1326.2006.00659.x","article-title":"Initial treatment with rosiglitazone\/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes","volume":"8","author":"Rosenstock","year":"2006","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jcjd.2013.04.008_bib21","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1463-1326.2006.00648.x","article-title":"Improvement in glycaemic control with rosiglitazone\/metformin fixed-dose combination therapy in patients with type 2 diabetes with very poor glycaemic control","volume":"8","author":"Rosenstock","year":"2006","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jcjd.2013.04.008_bib22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1463-1326.2005.00541.x","article-title":"Effect of early addition of rosiglitazone to sulphonylurea therapy in older type 2 diabetes patients (>60 years): the Rosiglitazone Early vs. SULphonylurea Titration (RESULT) study","volume":"8","author":"Rosenstock","year":"2006","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jcjd.2013.04.008_bib23","first-page":"S1","article-title":"Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada","volume":"32","year":"2008","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcjd.2013.04.008_bib24","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/bmj.39314.620174.80","article-title":"Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review","volume":"335","author":"Eurich","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.jcjd.2013.04.008_bib25","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.2337\/dc11-0512","article-title":"Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis","volume":"34","author":"Zhang","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2013.04.008_bib26","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1158\/1940-6207.CAPR-10-0157","article-title":"Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis","volume":"3","author":"Decensi","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.jcjd.2013.04.008_bib27","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1634\/theoncologist.2011-0462","article-title":"Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis","volume":"17","author":"Soranna","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.jcjd.2013.04.008_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2796.2004.01328.x","article-title":"The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review","volume":"256","author":"Wulffele","year":"2004","journal-title":"J\u00a0Intern Med"}],"container-title":["Canadian Journal of Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499267113007120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499267113007120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:23:32Z","timestamp":1761492212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499267113007120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1499267113007120"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjd.2013.04.008","relation":{},"ISSN":["1499-2671"],"issn-type":[{"type":"print","value":"1499-2671"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use Patterns of Antidiabetic Regimens by Patients with Type\u00a02 Diabetes","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjd.2013.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Canadian Diabetes Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}